Histology has a crucial role throughout the drug discovery and development pipeline, from early-stage R&D to clinical trials.
The tissue microenvironment plays a critical role in regulating disease. To develop targeted therapies, it is vitally important to study these pathogenic niches, to identify the cellular and molecular abnormalities driving disease. The understanding gained in these studies helps us make the best decisions for drug design and dose selection.
Watch this webinar to learn about:
- A range of histology techniques available for visualising and quantifying protein and mRNA expression
- Multiplex immunofluorescence (IF) and RNAscope
- Histology workflows
- Practical case studies showing how these workflows can be designed to inform drug discovery